SCIESCOPUSQ2
Lung Cancer-Targets and Therapy
DOVE MEDICAL PRESS LTD, New Zealand
Lung Cancer-Targets and Therapy is an academic journal published by DOVE MEDICAL PRESS LTD (New Zealand). Identifiers: eISSN 1179-2728. Indexed in SCIE, SCOPUS. Metrics: JIF 3.3, CiteScore 9.3, SJR 1.415, SNIP 0.81. Subject areas: ONCOLOGY. tlooto lists 187 papers from this journal.
CiteScore
9.30
Scopus citation metric
SJR
1.415
SCImago rank
SNIP
0.81
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 1179-2728
- Abbreviation
- LUNG CANCER-TARGETS
- Publisher
- DOVE MEDICAL PRESS LTD
- Country
- New Zealand
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2730 Oncology
Papers in this journal
Recent papers
- Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
2026
- Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges
2026
- HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib - A Case Report.
2026
- Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer.
2026
- Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
2026
Most cited papers
- Silicosis and lung cancer: current perspectives
2018 · 95 citations
- Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects
2017 · 86 citations
- Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
2017 · 84 citations
- miRNA-21 as a novel therapeutic target in lung cancer
2016 · 82 citations
- Radiation-induced esophagitis in lung cancer
2016 · 71 citations